Pforte Helmholtz Munich Banner

We are Helmholtz Munich.

We discover breakthrough solutions for better health in a rapidly changing world.

We discover breakthrough solutions for better health in a rapidly changing world.

Our Vision & Mission

Our world is constantly changing. This impacts our health. Many widespread diseases such as diabetes, allergies and lung diseases are on the rise. Climate change is causing new diseases to emerge.

We develop solutions for a healthier future. Our cutting-edge research is the springboard for medical innovations. Together with our partners, we accelerate the transfer from ideas to applications, from labs to startups, from science to society.

Our Management

Porträt Martin Hrabe de Angelis
Querformat
Background: Office / Indoorplant
Prof. Dr. Dr. h.c. mult. Martin Hrabě de Angelis

Member and Spokesperson of the Executive Board (acting)

View profile
Michael Frieser
Dr. Michael Frieser

Administrative Managing Director

View profile

Helmholtz Munich in Numbers

2555
Employees
90
Nations
1371
Publications in 2024
422
PhD students
31
Spin-Offs
66
ERC Grants

Member of the Helmholtz Association

  • We belong to the largest research network in Germany.
  • We receive long-term core funding for our research projects.
  • We offer our scientists an excellent infrastructure.

Our Locations

How We Work

Awards & Grants

See all
Rise up! funding program Daniel Kotlarz

Awards & Grants, Computational Health, ITG,

Funding to Advance Precision Medicine for Inflammatory Bowel Disease in Children

Daniel Kotlarz, group leader at the Institute of Translational Genomics at Helmholtz Munich and Heisenberg Professor of Precision Medicine of Pediatric Inflammatory Bowel Diseases at LMU University Hospital Munich receives around 600,000 Euros…

FEBS|EMBO Women in Science Prize for Eleftheria Zeggini

Awards & Grants, Computational Health, ITG,

Eleftheria Zeggini Receives FEBS | EMBO Women in Science Award 2027

Prof. Eleftheria Zeggini has been awarded the FEBS | EMBO Women in Science Award 2027 for her pioneering contributions to human genomics and the translation of large-scale genetic discoveries into biological and clinical insights, alongside her…

Dancing Protein

Awards & Grants, Computational Health, ICB, Molecular Targets and Therapeutics, STB,

Reid Alderson Receives ERC Starting Grant for Protein-DANCE

Dr. Reid Alderson from the Institute of Structural Biology and the Institute of Computational Biology at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the Protein-DANCE project, he will develop a new…

Brain with neural Laptop

AI, Awards & Grants, Computational Health, HCA,

Marcel Binz Receives ERC Starting Grant for MIDAS

Dr. Marcel Binz from the Institute for Human-Centered AI at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the MIDAS project, he will develop large-scale computational models designed to simulate,…

Marie Curie Statue

Awards & Grants, Diabetes, IDOT, Stem Cells,

Two MSCA Postdoctoral Fellowships Awarded to Researchers at Helmholtz Munich

Dr. Robert Frömel and Dr. Hossam Montaser have been awarded Marie Skłodowska Curie Postdoctoral Fellowships. Over a period of two years, the EU funded fellowships will support their independent research projects on gene regulation in brain…

Portrait of Michael Witting

Core Facilities, Awards & Grants,

Michael Witting Receives Metabolomics Society Medal 2026

Dr. Michael Witting has been awarded the Metabolomics Society Medal 2026. The international scientific society recognizes his contributions to the advancement and application of metabolomics methodologies. The medal was presented during the opening…

Porträt Steffen Schneider

Awards & Grants, Computational Health, ICB,

Steffen Schneider Admitted to the Young Academy

Dr. Steffen Schneider of Helmholtz Munich and KI macht Schule gGmbH has been admitted as a new member of the Young Academy. Working at the interface of artificial intelligence, neuroscience, and statistical modelling, Schneider joins the Academy's…

Portrait of Prof. Heiko Lickert

Awards & Grants, Diabetes, IDR,

Heiko Lickert Receives ERC Proof of Concept Grant for Diabetes Research

Prof. Heiko Lickert has been awarded an ERC Proof of Concept (PoC) Grant from the European Research Council (ERC). The funding is intended to advance a novel regenerative therapeutic approach for type 2 diabetes from basic research into clinical…

Antje Körner Portait standing in nature

Awards & Grants, Diabetes, HI-MAG,

Antje Körner Receives Prestigious International Award for Research on Childhood Obesity

A major international distinction for Leipzig-based obesity research: Prof. Antje Körner has been awarded the Willendorf Award by the World Obesity Federation.

Portrait of Prof. Vasilis Ntziachristos

Awards & Grants, Bioengineering, IBMI,

Vasilis Ntziachristos Receives Future Insight Prize 2026

Prof. Vasilis Ntziachristos has been awarded the Future Insight Prize 2026 by Merck. The prize recognizes his pioneering contributions to non-invasive health sensing and is endowed with a research grant of €300,000.

Akademiepreis für Fabian Theis

AI, Awards & Grants, Computational Health, ICB,

Fabian Theis Receives Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities

Prof. Fabian Theis has been awarded the Akademiepreis of the Berlin-Brandenburg Academy of Sciences and Humanities. The Academy honors his pioneering work in computational biomedicine and the development of novel methods for biomedical data analysis.…

Marcus Conrad Elected to the Leopoldina

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Elected to the Leopoldina

Prof. Marcus Conrad has been elected a member of the German National Academy of Sciences Leopoldina. With this prestigious scientific honor, the Academy recognizes his outstanding contributions to the study of regulated cell death and its…

Portrait Stephan Herzig, Querformat;

Awards & Grants, Diabetes, IDC,

Stephan Herzig Receives the 2026 Friedrich Arnold Gries Award from the DDG

Prof. Stephan Herzig has been awarded the 2026 Friedrich Arnold Gries Award by the German Diabetes Association (DDG). The award recognizes his outstanding scientific work on “Molecular characterization and therapeutic exploitation of…

Michele Solimena

Awards & Grants, Diabetes, IPI,

Michele Solimena Honored With the 2026 Paul Langerhans Medal of the DDG

Prof. Michele Solimena received the Paul Langerhans Medal, the highest award of the German Diabetes Society (DDG), on May 15, 2026. The prize recognizes his outstanding lifetime scientific achievements in the field of diabetes research. The…

Screenshot pancreas für research area "type 1 diabetes pathology" (Teresa Rodgriguez-Calvo)

Awards & Grants, Diabetes, IDF,

New Funding Supports Research into Causes and Treatment of Type 1 Diabetes

Dr. Teresa Rodriguez-Calvo from Helmholtz Munich has been awarded two prestigious grants from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support two innovative projects at the…

Our Organization

How is Helmholtz Munich funded?

Helmholtz Munich is a research institution owned by the Federal Government of Germany and the Free State of Bavaria which finance the center in a ratio of 90:10. In 2020, the funding amounted to 271.5 million euros. Addiotional third-party funding resulted in a total budget of 331,6 million euros in 2020.

How does Helmholtz Munich develop its research goals?

The centers of the Helmholtz Association are divided into six research fields:

  • Health
  • Energy
  • Earth and Environment
  • Aeronautics, Space and Transport
  • Information
  • Matter

For each research area, scientists develop research programs that are evaluated by international experts. This evaluation forms the basis for the program-oriented funding of Helmholtz research. Helmholtz Munich is fully anchored in the research field Health. For the current period our research is orientated towards the five topics of the program-oriented funding "Environmental and Metabolic Health" (ENABLE). This program provides the strategic research framework for Helmholtz Munich for the next seven years.

Helmholtz Munich is also part of Helmholtz Health. Together with five other Helmholtz Health Centers, we develop solutions for a healthier society in a network of cutting-edge biomedical research that is unique in Europe. Our mission is to translate research results as quickly as possible into advances for our society, our healthcare system and the economy. In order to continuously expand the transfer portfolio, to further increase the speed of transfer and to make essential contributions more effectively, Helmholtz Health is jointly pursuing a seven-point charter across the centers.

Supervisory Board

The Supervisory Board monitors the legality, expediency and economic efficiency of the work of the Board of Directors. It decides on the general research objectives, important research policy and financial matters, and the principles for performance review. The Supervisory Board currently has eight members. Of these, the shareholders (Federal Republic of Germany represented by the Federal Ministry of Research, Technology and Space, Free State of Bavaria represented by the Bavarian State Ministry of Finance and Home Affairs) delegate five members. In addition, there are three further members from the Saxon State Ministry of Science, Culture and Tourism and representatives of science and business.

Chairman: MinDir Thomas Romes

Board of Directors

The Board of Directors acts in accordance with the law, the Articles of Association, the Rules of Procedure and the instructions of the Shareholders' Meeting and the Supervisory Board. It shall cooperate with the other bodies of the Center.  

Member and Spokesperson of the Executive Board (acting): Prof. Dr. Dr. h.c. mult. Martin Hrabě de Angelis
Administrative Managing Director: Dr. Michael Frieser

Management Committee

The Management Committee advises the Board of Directors and makes recommendations on upcoming decisions on important matters, those of a fundamental nature and those of significant financial importance. Members of the Management Committee are scientific and administrative executives.

Chairman: Prof. Dr. Dr. h.c. mult. Martin Hrabě De Angelis 

Scientific Advisory Board

The Scientific Advisory Board advises the Supervisory Board and the Board of Directors. It is also responsible for evaluating the work of Helmholtz Munich. At present, eleven external scientists belong to the scientific advisory board.

Chairman: Prof. W. Langhans

Works Council

The works council is the elected representative body of the Helmholtz Munich employees and represents their interests vis-à-vis the Board of Directors.

Contact: betriebsratspam prevention@helmholtz-munich.de

Organization Chart

Please find our Organization Chart here.

Building a better world?

Join our team.